Ranolazine and Imdur drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranolazine (ranolazine) and Imdur (isosorbide mononitrate). Common drug interactions include hypotension among females and myocardial infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Ranolazine and Imdur. It is created by eHealthMe based on reports of 92 people who take the same drugs from the FDA, and is updated regularly.

What is Ranolazine?

Ranolazine has active ingredients of ranolazine. eHealthMe is studying from 9,939 Ranolazine users. Check the latest studies of Ranolazine.

What is Imdur?

Imdur has active ingredients of isosorbide mononitrate. It is often used in angina. eHealthMe is studying from 17,367 Imdur users. Check the latest studies of Imdur.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

92 people who take Ranolazine and Imdur together, and have interactions are studied.

Ranolazine and Imdur drug interactions.

What are the common drug interactions of Ranolazine and Imdur, by gender? *:

female:

  1. Hypotension (abnormally low blood pressure)
  2. Abdominal pain upper
  3. Adverse drug reaction
  4. Asthenia (weakness)
  5. Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain)
  6. Chronic kidney disease
  7. Confusional state
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Dehydration (dryness resulting from the removal of water)
  10. Face injury

male:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Hypotension (abnormally low blood pressure)
  3. Dizziness
  4. Blood pressure decreased
  5. Cardiac failure
  6. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  7. Death
  8. Fall
  9. Hallucination (an experience involving the perception of something not present)
  10. Hypersensitivity

What are the common drug interactions of Ranolazine and Imdur, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Diarrhoea

40-49:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Infection
  3. Laryngeal injury
  4. Neck injury
  5. Road traffic accident
  6. Chest pain
  7. Erythema (redness of the skin)
  8. Feeling hot
  9. Flushing (the warm, red condition of human skin)
  10. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

50-59:

  1. Stent placement
  2. Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue)
  3. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  4. Back pain
  5. Cardiac failure congestive
  6. Coronary arterial stent insertion
  7. Coronary artery bypass
  8. Diastolic dysfunction
  9. Disability
  10. Fluid retention (an abnormal accumulation of fluid in the blood)

60+:

  1. Chest pain
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Headache (pain in head)
  4. Injury
  5. Cardiac failure congestive
  6. Confusional state
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Anaemia (lack of blood)
  9. Arthralgia (joint pain)
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

What are the existing conditions these people have? *

  1. Stable Angina (a constant chest pain): 45 people, 48.91%
  2. High Blood Pressure: 14 people, 15.22%
  3. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 11 people, 11.96%
  4. Chest Pain: 9 people, 9.78%
  5. Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 7.61%
  6. Type 2 Diabetes: 5 people, 5.43%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 5.43%
  8. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 5.43%

* Approximation only. Some reports may have incomplete information.

Do you take Ranolazine and Imdur?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ranolazine and Imdur:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ranolazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Imdur:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranolazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imdur and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ranolazine and isosorbide mononitrate (the active ingredients of Ranolazine and Imdur, respectively), and Ranolazine and Imdur (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: